Apotex Pharmaceutical Holdings Inc.
Apotex Pharmaceutical Holdings Inc., a leading Canadian pharmaceutical company, is headquartered in Toronto, Ontario. Founded in 1974, Apotex has established itself as a key player in the global generic and specialty pharmaceuticals industry, with a strong presence in North America, Europe, and other international markets. The company is renowned for its extensive portfolio of over 300 generic medications, which are designed to provide affordable alternatives to brand-name drugs. Apotex's commitment to quality and innovation has earned it a reputation for excellence, making it one of the largest producers of generic pharmaceuticals in Canada. With a focus on research and development, Apotex continues to expand its offerings, contributing significantly to the accessibility of essential medications worldwide. Its notable achievements include numerous FDA approvals and a robust pipeline of new products, solidifying its position as a trusted leader in the pharmaceutical sector.
DitchCarbon Score
How does Apotex Pharmaceutical Holdings Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apotex Pharmaceutical Holdings Inc.'s score of 23 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apotex Pharmaceutical Holdings Inc.'s reported carbon emissions
Apotex Pharmaceutical Holdings Inc., headquartered in Canada, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Apotex has not established any commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without available emissions data or reduction initiatives, it is unclear how the company is addressing climate change within its operations. In the broader pharmaceutical industry context, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce greenhouse gas emissions. However, Apotex has yet to publicly align with these trends or disclose any specific climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apotex Pharmaceutical Holdings Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
